English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 28 January 2019, 08:30 HKT/SGT
Share:
DBS: Leasing Sector Embraces The Super Up-Cycle; Top Buys: Far East Horizon(3360.HK)

HONG KONG, Jan 28, 2019 - (ACN Newswire) - DBS recently issued a research report on China leasing sector, which indicated that it will be set to benefit from China's ongoing deleveraging campaign, continuous expansion in manufacturing and infrastructure FAI. Far East Horizon was listed as top buys, with initiate coverage with BUY and target price of HK$10.3, implying a 35% upside.


DBS pointed out that it should be focused on the profitability changes of Far East Horizon rather than its asset growth as it prefers to be less aggressive in expanding amid macro uncertainties in the future. The core leasing business of Far East Horizon will be benefit from macro-trends changes. Far East Horizon is well positioned in selective segments including urban public utility, healthcare and education, accounting for 59% of its total interest earnings asset in 1H2018. With 70% of its customers coming from state-owned enterprises, Far East Horizon is well balanced between risk and reward of its assets and customers portfolio. It expected that the funding cost of Far East Horizon will continuously benefit from lower market interest rate, and the asset quality will remain benign in 2019.

DBS considered that the deployment in hospital operations of Far East Horizon is also expected to help mitigate the volatility in core leasing business, providing stable income streams and create business synergies. Far East Horizon first entered the hospital-operation business back in 2014. It has been expanding throughout the years and operated 43 medical service institutions in 1H2018. Its total number of hospital beds had reached 16,000, with a 2018 full-year target of reaching 20,000 beds, the hospital operator with the largest bed capacity in China. DBS believed that the profit growth of Far East Horizon will accelerate once it has gained better economies of scale. Furthermore, its deployment in the hospital operation will also help to create synergy, improving industry know-how and credit risk awareness of its financial leasing business.

DBS believed that the share price of Far East Horizon is significantly undervalued, as its current share price reflects zero value of its hospital operation, and the leasing business is also undervalued by the market. Based on SOTP valuation, DBS initiated Far East Horizon with BUY and target price of HK$10.3, which implies a 35% upside.


Topic: Press release summary Sectors: Daily Finance, Daily News
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Niyo Doubles Click-Through Rates and Improves Customer Retention with CleverTap  
Nov 28, 2024 14:30 HKT/SGT
Survey: New Opportunities in Cross-border E-commerce  
Nov 28, 2024 14:05 HKT/SGT
Cropmate Berhad IPO Oversubscribed by 84.88 Times  
Nov 28, 2024 14:00 HKT/SGT
SF Holding successfully listed in Hong Kong  
Nov 28, 2024 14:00 HKT/SGT
EdgePoint Infrastructure Inks Strategic Partnership with CelcomDigi to expand connectivity in Malaysia at TowerXchange Meet Up Asia 2024  
Nov 28, 2024 13:40 HKT/SGT
Hitachi High-Tech Launches DCR Etch System 9060 Series, Supporting Isotropic Etching of Advanced 3D Devices at the Atomic Level  
Thursday, November 28, 2024 10:31:00 AM
SCIB Reports 14.6% Revenue Growth to RM45.1 Million in Q1FY2025  
Nov 28, 2024 10:00 HKT/SGT
MHI Delivers Final Trainset of Automated Guideway Transit System "2020 Series" to Saitama New Urban Transit  
Thursday, November 28, 2024 9:08:00 AM
foundit Insights Tracker Reveals 20% Surge in Hiring Activity in the Philippines: A Beacon for Southeast Asia  
Nov 28, 2024 06:00 HKT/SGT
LANGHAM BEAUTY Green Vitality  
Nov 27, 2024 23:20 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575